NCT00189436 - Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions

Asthma

Interventions

DRUG

Nebulized Budesonide

Subject is treated with nebulized budesonide 0.5 BID for 3 weeks

DRUG

Usual care (albuterol with or without oral steroid)

Subject is treated with usual care as prescribed by the doctor (normally albuterol with or without oral steroid)

Trial Locations (2)

Bellevue Pediatric Associates, Bellevue

Allegheny General Hospital, Pittsburgh